Steven T Rosen

9PUBLICATIONS
44CO-AUTHORS
Chemical engineering designCancer therapy (excl. chemotherapy and radiation therapy)Banking, finance and securities lawMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 28, 2026
Calcitriol-PKM2 axis drives transcriptional and metabolic reprogramming of ILCPs into intestinal dual-cytokine-producing ILC3s.

|Jan 01, 2026
International Cost-Effectiveness Analysis of Nivolumab Versus Brentuximab Vedotin for Patients With Advanced-Stage Classic Hodgkin's Lymphoma.

Youwen Zhu, Kun Liu, Steven T Rosen

|Feb 14, 2025
Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphoma.

Christiane Querfeld, Joycelynne Palmer, Zhen Han

|Feb 27, 2024
Congressional Investigation of RevAssist-Linked and General Pricing Strategies for Lenalidomide.

Charles L Bennett, Jason B Gibbons, Antonio Trujillo

|May 29, 2023
P38 kinase in gastrointestinal cancers.

Thuy Phan, Xu Hannah Zhang, Steven Rosen

|Apr 17, 2023
METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL.

Yiming Wu, Meiling Jin, Mike Fernandez

Pageof 2

Frequent Collaborators

2 joint publications

Christiane Querfeld

2 joint publications

Raju Pillai

1 joint publications

Laleh G Melstrom

1 joint publications

Qingyang Liu